SkylineDx announced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics. Under...
Sorriso Pharmaceuticals, a company focused on transforming anti-inflammatory antibody therapy, announced the company has closed on a $31 million Series A financing. The round...
AT&T Inc. has agreed to sell its global programmatic advertising marketplace, Xandr Inc., to Microsoft.1 The agreement builds on a decade-long relationship between Xandr,...
Exopharm Limited has been granted US patent US 11202805 for its LEAP exosome purification technology. This patent positions Exopharm as a global leader in...
